A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 506-511

  Calabresi, Laura ^a   Nilsson, Peter ^b   Pinotti, Elisa ^c   Gomaraschi, Monica ^a   Favari, Elda ^d   Adorni, Maria Pia ^d   Bernini, Franco ^d   Sirtori, Cesare R ^a   Calandra, Sebastiano ^c   Franceschini, Guido ^a   Tarugi, Patrizia ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Cell cholesterol efflux; CETP deficiency; CETP gene; High density lipoproteins; Primary hyperalphalipoproteinemia; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI;

ADULT; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CASE REPORT; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; EXON; FEMORAL ARTERY; GENETIC PREDISPOSITION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; STOP CODON;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FAMILY HEALTH; FEMALE; FEMORAL ARTERY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 67650892211     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.006     Document Type: Article

References (30)

1. Nagano M., Yamashita S., Hirano K., et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 11 (2004) 110-121
2. Bruce C., and Tall A.R. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 6 (1995) 306-311
3. de Grooth G.J., Klerkx A.H., Stroes E.S., et al. A review of CETP and its relation to atherosclerosis. J Lipid Res 45 (2004) 1967-1974
4. Tall A.R., Breslow J.L., and Rubin E.M. Genetic disorders affecting plasma high-density lipoproteins. In: Scriver C.R., Beaudet A.L., Valle D., and Sly W.S. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. vol. II (2001), McGraw Hill, New York p. 2915-2936
5. Drayna D., Jarnagin A.S., McLean J., et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327 (1987) 632-634
6. Maruyama T., Sakai N., Ishigami M., et al. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia. Atherosclerosis 166 (2003) 177-185
7. Brown M.L., Inazu A., Hesler C.B., et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342 (1989) 448-451
8. Inazu A., Brown M.L., Hesler C.B., et al. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 323 (1990) 1234-1238
9. Takahashi K., Jiang X.C., Sakai N., et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest (1993) 2060-2064
10. Inazu A., Jiang X.C., Haraki T., et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94 (1994) 1872-1882
11. Funke H., Wiebusch H., Fuer L., et al. Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation 90 I-241 (1994) [Abstract]
12. Teh E.M., Dolphin P.J., Breckenridge W.C., et al. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J Lipid Res 39 (1998) 442-456
13. Rhyne J., Ryan M.J., White C., et al. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. J Mol Med 84 (2006) 647-650
14. van der Steeg W.A., Hovingh G.K., Klerkx A.H., et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians. J Lipid Res 48 (2007) 674-682
15. Berglund G., Eriksson K.F., Israelsson B., et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 239 (1996) 489-497
16. den Dunnen J.T., and Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15 (2000) 7-12
17. den Dunnen J.T., and Paalman M.H. Standardizing mutation nomenclature: why bother?. Hum Mutat 22 (2003) 181-182
18. Calabresi L., Pisciotta L., Costantin A., et al. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25 (2005) 1972-1978
19. Murakami T., Michelagnoli S., Longhi R., et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 15 (1995) 1819-1828
20. Hedblad B., Nilsson P., Janzon L., et al. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med 17 (2000) 299-307
21. Asztalos B.F., Horvath K.V., Kajinami K., et al. Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency. J Lipid Res 45 (2004) 448-455
22. Jonas A. Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529 (2000) 245-255
23. Oliveira H.C., Ma L., Milne R., et al. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler Thromb Vasc Biol 17 (1997) 1045-1052
24. Favari E., Lee M., Calabresi L., et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding Cassette Transporter A1- but not Scavenger Receptor Class B Type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 279 (2004) 9930-9936
25. Jessup W., Gelissen I.C., Gaus K., and Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 17 (2006) 247-257
26. Mulya A., Lee J.Y., Gebre A.K., et al. Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1. Arterioscler Thromb Vasc Biol 27 (2007) 1828-1836
27. Van Eck M., Bos I.S., Kaminski W.E., et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 99 (2002) 6298-6303
28. Bots M.L., Visseren F.L., Evans G.W., et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 370 (2007) 153-160
29. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357 (2007) 2109-2122
30. Tanigawa H., Billheimer J.T., Tohyama J., et al. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 116 (2007) 1267-1273